ANI Pharmaceuticals, Inc. - Common Stock (ANIP)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- Trading 72% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 8/9 — financially strong with improving fundamentals
- ROE of 14.3% — below-average profitability
- Revenue growing at 44% annually
ANI Pharmaceuticals, Inc. - Common Stock (ANIP) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $1.7 billion . Key value metrics: P/E ratio 21.5, P/B ratio 3.08, Piotroski F-Score 8 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
ANI Pharmaceuticals, Inc. - Common Stock — Fundamental Analysis Summary
ANI Pharmaceuticals, Inc. - Common Stock (ANIP) is currently trading 72% above its Graham Number of $48.21, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 21.5x.
On financial health, ANIP shows a strong Piotroski F-Score of 8/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 14.3% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.51.
StockPik's composite Value Score for ANIP is 80/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ANIP reports a solid gross margin of 58.2% (sector average: 40.1%) and a solid operating margin of 13.2%.
ANIP shows revenue growing at 44% year-over-year, with earnings growing at 523%.